A recent study suggests that individuals who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Research printed in a prominent health publication shows that while obese individuals often shed substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month after stopping.
"Users buying these treatments must be cognizant of the danger of quick rebound weight gain when the medication is stopped," cautioned expert Dr. Susan Jebb.
This pace of regain means a reversion to starting mass within about one and a half years.
Analyzing Treatments
The study, which reviewed 37 of trials involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers point out that people who lose weight through dieting usually have a slower creep back—perhaps 100 grams monthly—once they finish.
Understanding the Fast Regain
Nutrition scientists suggest the mechanism of the jabs accounts for the heightened regain.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates hunger.
"Artificially providing the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement means hunger is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
The NHS suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, given the high risk of relapse, the therapy should be considered life-long.
This view is supported by drug manufacturers, who note that the findings "underscore the chronic character of obesity," similar to managing conditions like diabetes.
Patient Testimonies
People who have come off the jabs explain a sudden resurgence of appetite.
"It felt as if a switch activating and you become starving," recalled one woman.
This difficulty is compounded if users have not established lasting lifestyle or habit modifications during treatment.
Significant Interest
Recent estimates indicate that millions of people in the UK have used these injections in the last 12 months, with desire remaining high.
- Use is more common among females than males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than public health services.
In conclusion, researchers caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic fix and maintained weight loss likely depends on integrated lifestyle changes.
